Skip to main content
Top
Published in: Reactions Weekly 1/2015

01-04-2015 | Case report

Caspofungin/micafungin

Development of candida albicans resistance and its complications: case report

Published in: Reactions Weekly | Issue 1/2015

Login to get access

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literature
go back to reference Chrenkova V, et al. Post-mortem analysis of candida albicans breakthrough infection during echinocandin treatment in haematopoietic stem cell transplant recipient. Epidemiologie, Mikrobiologie, Imunologie 63: 121-124, No. 2, Jun 2014 - Czech RepublicPubMed Chrenkova V, et al. Post-mortem analysis of candida albicans breakthrough infection during echinocandin treatment in haematopoietic stem cell transplant recipient. Epidemiologie, Mikrobiologie, Imunologie 63: 121-124, No. 2, Jun 2014 - Czech RepublicPubMed
Metadata
Title
Caspofungin/micafungin
Development of candida albicans resistance and its complications: case report
Publication date
01-04-2015
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2015
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-9160-9

Other articles of this Issue 1/2015

Reactions Weekly 1/2015 Go to the issue

Case report

Silver

Case report

Cyclophosphamide

Case report

Iodine-131

Case report

Tocilizumab

Case report

Methotrexate